Hexagon Nutrition Limited
NSE: HEXAGONPackaged FoodsTrade-to-trade true
Share price
₹69.43
+1.22% close of 9 Oct 2026
Price-based ratios (P/B, dividend yield, EV/EBITDA) are as of 8 Oct 2026, the close above is 9 Oct 2026.
Business score
How strong the business is, in one number. The parts behind it are in Pro.
63
out of 100 · worked out 8 Oct 2026
Your ratios
The numbers you want to see first. Tap Edit to change them.
Market cap
₹853 Cr
P/E ratio
22.4
P/B ratio
3.3
ROCE
21.8%
ROE
16.9%
Dividend yield
0.4%
Price & valuation chart
How the share price and its valuation have moved. Hover over the chart to see any day. Prices as of the last close.
Answers
Simple answers to the questions investors ask most, from the company's own numbers.
How fast it has been growing
Fewer than three years of filings — too early to judge growth.
Whether it grew faster than its sector
It grew 10.7% a year against a sector median of 9.9% — 0.8 percentage points faster.
Room to re-rate, or risk of de-rating
Too little price history yet to compare it with its own past.
Whether growth justifies the valuation
It has no steady three-year profit record yet, so growth cannot be weighed against the price.
| Profit growth | Price per ₹1 profit | Per 1% growth | |
|---|---|---|---|
| Hexagon Nutrition Limited — this one | — | 22.4× | — |
| Zydus Wellness Limited | -10%/yr | 71.8× | — |
| Bikaji Foods International Limited | 24%/yr | 44.9× | ₹1.9 |
| The Bombay Burmah Trading Corporation Limited | 31%/yr | 6.9× | ₹0.22 |
| Mrs. Bectors Food Specialities Limited | 16%/yr | 42.2× | ₹2.6 |
| ADF Foods Limited | 20%/yr | 32.8× | ₹1.6 |
Compared with companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
How it compares with its peers
Against companies the exchange files under the same label (Packaged Foods), it ranks 5 of 20 on returns, 10 of 20 on growth, 8 of 20 on margin. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
What makes it hard to beat — and is that still true?
A wide advantage: it earns 21.8% on capital, ahead of 75% of companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
Whether its growth pays for itself
Yes — Over the last five years it made ₹107 crore of cash from the business, spent ₹55 crore on plant and equipment, and returned ₹40 crore to lenders and shareholders. And the profit is real: of every 100 rupees it reported over 5 years, about 89 arrived as cash. Its cash comes back more slowly than it used to: it went from being waiting 94 days for its cash to waiting 110 days for its cash.
Profit reality check
Is the profit real cash? Simple checks on the accounts. Facts only, not advice.
7 of 8 checks clear · 88%
Latest result · Q1 FY27
What the last results showed. Whether management kept its word is in Pro.
Announced 12 Aug 2026 · Consolidated · Unaudited
Revenue
₹104 Cr
Revenue vs last quarter
-9.3%
Net profit
₹8 Cr
Profit vs last quarter
-26.6%
Net margin
7.7%
EPS
₹0.67
Earnings call transcript · 14 Aug 2026
Checklist before you investPRO
Points for and against, in one list.
Key numbers & peers
The main numbers grouped by topic, and how the company compares with similar ones.
Price
- Market cap
- ₹853 Cr
- Prev close
- ₹69.43
- 52w High
- ₹78.3
- 52w Low
- ₹48.1
- Enterprise value
- ₹821 Cr
- Beta
- —
- Price CAGR 1y
- —
- Price CAGR 3y
- —
- Price CAGR 5y
- —
- Price CAGR 10y
- —
Ratios
- Return on assets
- 11.9%
- PEG ratio
- —
- P/E ratio
- 22.4
- P/B ratio
- 3.3
- EV / EBITDA
- 15.0
- Industry P/E
- 43.5
- ROCE
- 21.8%
- ROCE 5y average
- 19.3%
- ROE
- 16.9%
- Debt / Equity
- 0.1
- Interest coverage
- 13.8
- Dividend yield
- 0.4%
- ROE 3y average
- 13.0%
- ROE last year
- 17.0%
Annual P&L
- Annual revenue
- ₹380 Cr
- Annual profit
- ₹38 Cr
- Operating margin
- 14.0%
- Net profit margin
- 10.0%
- EBITDA margin
- 13.9%
- Sales growth 3y
- 11.9%
- Sales growth 5y
- 13.0%
- Profit growth 3y
- —
- Profit growth 5y
- 11.0%
- EPS
- ₹3.4
- Sales growth TTM
- 17.0%
- Profit growth TTM
- 53.0%
- Dividend payout
- 0.0%
Quarter P&L
- Sales latest quarter
- ₹104 Cr
- Profit latest quarter
- ₹8 Cr
- YoY quarterly sales growth
- 43.2%
- YoY quarterly profit growth
- 24.9%
- OPM latest quarter
- 11.3%
Balance Sheet
- Book Value
- ₹19.0
- Face Value
- ₹1.0
- Total debt
- ₹33 Cr
- Total cash
- ₹18 Cr
- Borrowings
- ₹33 Cr
- Reserves / Equity
- 20.2
Cash Flow
- Operating cash flow
- ₹6 Cr
- Free cash flow
- -₹1 Cr
- FCF yield
- -0.6%
- Net cash flow
- ₹1 Cr
Shareholding
- Promoter holding
- 64.3%
- FII holding
- 0.3%
- DII holding
- 6.4%
- Public holding
- 29.0%
Peer comparison
| Company | Price ₹ | P/E | Mkt cap ₹ Cr | Div yield % | Profit qtr ₹ Cr | Profit var % | Sales qtr ₹ Cr | Sales var % | ROCE % |
|---|---|---|---|---|---|---|---|---|---|
| Nestle India | 1,324.00 | 68.0 | 2,55,309 | 0.91 | 975.1 | 48.6 | 6,378.2 | 25.2 | 84.1 |
| Britannia Inds. | 4,780.00 | 44.2 | 1,15,135 | 1.89 | 593.4 | 13.6 | 5,000.0 | 8.2 | 56.0 |
| Zydus Wellness | 507.55 | 72.9 | 16,148 | 0.24 | 118.9 | -7.0 | 1,437.0 | 66.9 | 4.9 |
| Bikaji Foods | 483.55 | 43.7 | 12,124 | 0.26 | 64.6 | 2.2 | 678.2 | 8.7 | 22.0 |
| The Bombay Burmah | 1,269.40 | 7.2 | 8,857 | 1.34 | 582.7 | 17.5 | 5,088.7 | 8.0 | 33.0 |
| Mrs Bectors | 211.07 | 50.2 | 6,480 | 0.62 | 35.3 | 41.8 | 507.1 | 15.7 | 12.9 |
| ADF Foods | 291.70 | 33.1 | 3,205 | 0.41 | 17.3 | 13.4 | 167.3 | 25.9 | 21.8 |
| Hexagon Nutri. | 71.97 | 23.8 | 885 | 0.42 | 8.1 | 24.5 | 104.3 | 43.2 | 21.8 |
| Median | 250.20 | 44.2 | 722 | 0.04 | 8.5 | 23.0 | 139.8 | 15.7 | 14.0 |
Competes with: ADF Foods Limited, Bikaji Foods International Limited, Britannia Industries, Gopal Snacks Limited, Mrs. Bectors Food Specialities Limited, Nestle India, The Bombay Burmah Trading Corporation Limited, Zydus Wellness Limited
Quarterly results
Sales and profit for each of the last 13 quarters. Newest on the right. ₹ crore.
| Line item | Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Sales | 107 | 73 | 100 | 115 | 104 |
| Expenses | 94 | 63 | 84 | 100 | 93 |
| Material Cost | 55 | 67 | |||
| Change in Inventories | 9.31 | -9.84 | |||
| Purchases of Stock-in-Trade | 0 | 1.26 | |||
| Employee Cost | 14 | 14 | |||
| Other Expenses | 21 | 20 | |||
| Operating Profit | 13 | 10 | 15 | 15 | 12 |
| OPM % | 12 | 14 | 15 | 13 | 11 |
| Other Income | 0.69 | 1.39 | 2.26 | 4.25 | 2.14 |
| Exceptional items (within Other Income) | 0.30 | 0.06 | |||
| Interest | 1.01 | 0.80 | 1.11 | 1.13 | 0.98 |
| Depreciation | 2.30 | 2.17 | 2.49 | 2.75 | 2.30 |
| Profit before tax | 10 | 8.47 | 14 | 15 | 11 |
| Tax % | 23 | 24 | 25 | 29 | 24 |
| Net Profit | 7.76 | 6.46 | 10 | 11 | 8.07 |
| EPS in Rs | 0.70 | 0.58 | 0.94 | 0.99 | 0.66 |
| Diluted EPS in Rs | 0.89 | 0.66 |
Profit & loss
Yearly sales, costs and profit for 12 years, plus the last 12 months (TTM). ₹ crore.
| Line item | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 211 | 271 | 298 | 325 | 383 |
| Expenses | 177 | 235 | 273 | 283 | 327 |
| Material Cost | 202 | ||||
| Change in Inventories | -3.19 | ||||
| Purchases of Stock-in-Trade | 0.26 | ||||
| Employee Cost | 50 | ||||
| Other Expenses | 80 | ||||
| Operating Profit | 34 | 36 | 25 | 41 | 53 |
| OPM % | 16 | 13 | 8 | 13 | 14 |
| Other Income | 6 | 5 | 7 | 6 | 12 |
| Exceptional items (within Other Income) | 0.31 | ||||
| Interest | 3 | 2 | 4 | 4 | 4.02 |
| Depreciation | 6 | 7 | 8 | 8.77 | 9.64 |
| Profit before tax | 31 | 32 | 20 | 34 | 51 |
| Tax % | 27 | 28 | 37 | 28 | 26 |
| Net Profit | 23 | 23 | 12 | 24 | 38 |
| EPS in Rs | 2.07 | 2.11 | 1.10 | 2.20 | 3.43 |
| Diluted EPS in Rs | 3.09 | ||||
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 |
Compounded growth
Average yearly growth over different spans, as stored. A span can cross a demerger or an acquisition.
Compounded sales growth
- 10 years
- —
- 5 years
- 13%
- 3 years
- 12%
- TTM
- 17%
Compounded profit growth
- 10 years
- —
- 5 years
- 11%
- 3 years
- —
- TTM
- 53%
Return on equity
- 10 years
- —
- 5 years
- —
- 3 years
- 13%
- Last year
- 17%
Balance sheet
What the company owns and what it owes, at the end of each year. ₹ crore.
| Line item | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity Capital | 11 | 11 | 11 | 11 | 11 |
| Reserves | 127 | 149 | 153 | 183 | 222 |
| Borrowings | 20 | 40 | 49 | 29 | 33 |
| Other Liabilities | 55 | 57 | 38 | 38 | 52 |
| Total Liabilities | 214 | 257 | 251 | 261 | 318 |
| Fixed Assets | 51 | 55 | 65 | 64 | 64 |
| CWIP | 1 | 7 | 2 | 4 | 3 |
| Investments | 18 | 23 | 19 | 34 | 37 |
| Other Assets | 144 | 172 | 164 | 159 | 215 |
| Total Assets | 214 | 257 | 251 | 261 | 318 |
Cash flows
Real money coming in and going out each year — from the business, from investments and from loans. ₹ crore.
| Line item | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Cash from Operating Activity | 29 | 11 | 23 | 38 | 6.23 |
| Cash from Investing Activity | -9 | -21 | 4 | -23 | -5 |
| Cash from Financing Activity | -18 | 16 | -19 | -19 | -0 |
| Net Cash Flow | 1 | 6 | 8 | -4 | 1 |
| Free Cash Flow | 21 | -5 | 8 | 29 | -1.38 |
Ratios
How fast customers pay, how long stock sits, and how well capital earns — year by year.
| Line item | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debtor Days | 70 | 76 | 59 | 67 | 79 |
| Inventory Days | 192 | 146 | 161 | 124 | 153 |
| Days Payable | 114 | 79 | 40 | 38 | 53 |
| Cash Conversion Cycle | 148 | 143 | 181 | 153 | 179 |
| Working Capital Days | 94 | 72 | 93 | 87 | 110 |
| ROCE % | 19 | 17 | 22 |
Price trend
The price as a Renko brick chart: small moves drop out so the bigger path stands out.
Every brick is the same size, about one typical day's move. A new brick needs a full brick's move; turning the other way needs two. Bricks show where the price went, not where it will go.
Open interestPRO
Where option traders are positioned on this stock.
Industry numbers
The numbers that matter most in this industry, from the company's own filings.
1 when an audit qualification is filed as repetitive
0.00flag
2026-03-31
company capacity utilisation %
47.00pct
2026-06-30
the company's own unlisted debt securities in default at period end
0.00cr
2026-06-30
the company's own loans / revolving facilities in default at period end (standalone filing)
0.00cr
2026-06-30
net debt from the filed balance sheet at the newest year end: Borrowings − Cash Equivalents − Investments (Current); negative = net cash
-22.41inr_cr
2026-03-31
order book, Rs crore
100inr_cr
2026-06-30
News
News and filings about Hexagon Nutrition Limited. Open one to see why it matters.
29 Sept, 18:30 IST · Company event · low impact
Hexagon Nutrition Limited has launched a product
Supply chain
Who it buys from, sells to and competes with — as recorded in our map of company links.
Competes with
Uses as raw material
- Edible oil (RUTF/RUSF)
- Milk powder (RUTF/RUSF, clinical nutrition)
- Peanut / groundnut paste (RUTF, peanut-based therapeutic food)
- Sugar (RUTF/RUSF)
- Vitamin & mineral micronutrients (premix inputs)
Sells to
- UNICEF · Ready-to-Use Therapeutic Food (RUTF) + Micronutrient Powders (MNP) under UN procurement (E…
- World Food Programme (WFP) · RUTF / RUSF / MNPs for large-scale humanitarian nutrition programmes
About
What the company is, from our own records: where it sits, where it makes things, and what it is made of.
- Sector
- Fast Moving Consumer Goods
- Industry
- Packaged Foods
- Classification
- Fast Moving Consumer Goods › Packaged Foods
- ISIN
- INE0JUI01012
Plants
- Hexagon Nutrition — Chennai SEZ Plant
- Hexagon Nutrition — Nashik Plant
- Hexagon Nutrition — Tashkent Plant (Uzbekistan)
- Hexagon Nutrition — Thoothukudi SEZ Plant
News impact
Big market events that reach Hexagon Nutrition Limited, and how the effect spreads.
No recent market events reach this company.
Dividends, splits & big trades
Money paid out, share splits and buybacks, and big buys or sells by funds and insiders.
Dividends
| 15 Sep 2026 | unspecified | ₹0.3 |
|---|
Splits, bonuses & buybacks
- daily-prices repair: 1 rows from NSE's archive (replace 0, delete 1, insert 0), 2026-06-26..2026-06-26 (docs/flat_day_repair.md)1× · 26 Jun 2026
Bulk & block deals
| Date | Who | Bought / sold | Shares | Price |
|---|---|---|---|---|
| 16 Sep 2026 | CP CAPITAL LIMITED | SELL | 7,09,834 | ₹64.90 |
| 10 Jul 2026 | HRTI PRIVATE LIMITED | SELL | 6,23,681 | ₹73.83 |
| 10 Jul 2026 | HRTI PRIVATE LIMITED | BUY | 5,42,474 | ₹73.93 |
| 2 Jul 2026 | MATHISYS QUANTCAP LLP | BUY | 6,83,592 | ₹68.80 |
| 2 Jul 2026 | MATHISYS QUANTCAP LLP | SELL | 6,72,615 | ₹68.56 |
| 18 Jun 2026 | NAVRATRI SHARE TRADING PRIVATE LIMITED . | SELL | 6,30,000 | ₹49.43 |
| 16 Jun 2026 | NAVRATRI SHARE TRADING PRIVATE LIMITED . | BUY | 6,30,000 | ₹54.14 |
| 16 Jun 2026 | NAVRATRI SHARE TRADING PRIVATE LIMITED . | SELL | 6,30,000 | ₹50.78 |
| 12 Jun 2026 | SETU SECURITIES PVT LTD | BUY | 7,50,001 | ₹49.05 |
| 12 Jun 2026 | NAVRATRI SHARE TRADING PRIVATE LIMITED . | BUY | 6,30,000 | ₹48.51 |
Insider trades
| Disclosed | Who | Type | Shares | Value ₹ Cr |
|---|---|---|---|---|
| 19 Sep 2026 | MR. VIKRAM KELKAR · Promoter and Director | BUY | 10,000 | 0.07 |
| 19 Sep 2026 | DR. NIKHIL KELKAR · Promoter and Director | BUY | 10,000 | 0.06 |
| 19 Sep 2026 | MS. ANURADHA KELKAR · Promoter Group | BUY | 5,000 | 0.03 |
| 19 Sep 2026 | DR. NIKHIL KELKAR · Promoter and Director | BUY | 5,000 | 0.03 |
| 19 Sep 2026 | Ms Preeti Vikram Kelkar · Promoter Group | BUY | 5,000 | 0.03 |
| 19 Aug 2026 | DR. NIKHIL KELKAR · Promoter | BUY | 16,400 | 0.11 |
| 19 Aug 2026 | MR. VIKRAM KELKAR · Promoter | BUY | 16,300 | 0.10 |
| 19 Aug 2026 | MS. ANURADHA KELKAR · Promoter Group | BUY | 15,000 | 0.10 |
Documents
Annual reports, results presentations and earnings calls, straight from the source.
- Annual report · 2025-2631 Aug 2026
- Earnings call · Q1FY2714 Aug 2026
- Earnings call · Q4FY2617 Jul 2026
Facts from company filings and exchange data. Not investment advice: nothing here tells you to buy or sell.